3581 - 3581 |
Neuroproteomics: Deciphering Brain Dynamics Stevens SM, Kobeissy FH |
3582 - 3597 |
Application of proteomics to cerebrovascular disease Ning MM, Lopez M, Cao J, Buonanno FS, Lo EH |
3598 - 3607 |
Finding a pathological diagnosis for Alzheimer's disease: Are inflammatory molecules the answer? Bhamra MS, Ashton NJ |
3608 - 3616 |
Intraneuronal ss-amyloid and its interactions with proteins and subcellular organelles Penke B, Toth AM, Foldi I, Szucs M, Janaky T |
3617 - 3630 |
Use of proteomic methods in the analysis of human body fluids in Alzheimer research Zurbig P, Jahn H |
3631 - 3643 |
Proteomic analysis of prion diseases: Creating clarity or causing confusion? Rubenstein R |
3644 - 3652 |
Capillary electromigration based techniques in diagnostics of prion protein caused diseases Sobrova P, Ryvolova M, Adam V, Kizek R |
3653 - 3658 |
Genomic and proteomic advances in autism research Maurer MH |
3659 - 3668 |
Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma Raad M, El Tal T, Gul R, Mondello S, Zhang ZQ, Boustany RM, Guingab J, Wang KK, Kobeissy F |
3669 - 3679 |
Bioinformatics aggregation predictors in the study of protein conformational diseases of the human nervous system Guidolin D, Agnati LF, Albertin G, Tortorella C, Fuxe K |
3680 - 3692 |
Neurobehavioral, cellular, and molecular consequences of single and multiple mild blast exposure Kamnaksh A, Kwon SK, Kovesdi E, Ahmed F, Barry ES, Grunberg NE, Long J, Agoston D |
3693 - 3704 |
Proteomic analysis and brain-specific systems biology in a rodent model of penetrating ballistic-like brain injury Boutte AM, Yao CP, Kobeissy F, Lu XCM, Zhang ZQ, Wang KK, Schmid K, Tortella FC, Dave JR |
3705 - 3711 |
Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury Ahmed F, Gyorgy A, Kamnaksh A, Ling G, Tong L, Parks S, Agoston D |
3712 - 3719 |
High-capacity peptide-centric platform to decode the proteomic response to brain injury Cortes DF, Landis MK, Ottens AK |
3720 - 3727 |
Prion protein as a mediator of neurocardiosympathetic interactions Rubenstein R, Chiu A, Salciccioli L, Kamran H, Lazar J |
3728 - 3737 |
SILAC-based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal-like B103 cells Chaput D, Kirouac LH, Bell-Temin H, Stevens SM, Padmanabhan J |
3738 - 3744 |
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia Albertini V, Benussi L, Paterlini A, Glionna M, Prestia A, Bocchio-Chiavetto L, Amicucci G, Galluzzi S, Adorni A, Geroldi C, Binetti G, Frisoni GB, Ghidoni R |
3745 - 3755 |
Proteomic analysis of mice expressing human ApoE demonstrates no differences in global protein solubility between APOE 3 and APOE 4 young mice Londono C, DeKroon RM, Mocanu M, Booe J, Winnik WM, Swank A, Osorio C, Hamlett ED, Alzate O |
3756 - 3763 |
Quantitative proteomic analysis reveals that lipopolysaccharide induces mitogen-activated protein kinase-dependent activation in human microglial cells Byun K, Kim JY, Bayarsaikhan E, Kim D, Jeong GB, Yun KN, Min HK, Kim SU, Yoo JS, Lee B |
3764 - 3778 |
Radial nerve cord protein phosphorylation dynamics during starfish arm tip wound healing events Franco CF, Soares R, Pires E, Santos R, Coelho AV |
3779 - 3785 |
Neuroproteomic profiling of human brain tissue using multidimensional separation techniques and selective enrichment of membrane proteins Musunuri S, Shevchenko G, Bergquist J |
3786 - 3797 |
In vitro MS-based proteomic analysis and absolute quantification of neuronal-glial injury biomarkers in cell culture system Guingab-Cagmat JD, Newsom K, Vakulenko A, Cagmat EB, Kobeissy FH, Zoltewicz S, Wang KK, Anagli J |
3798 - 3809 |
CLN5 and CLN8 protein association with ceramide synthase: Biochemical and proteomic approaches El Haddad S, Khoury M, Daoud M, Kantar R, Harati H, Mousallem T, Alzate O, Meyer B, Boustany RM |
3810 - 3819 |
Microwave and magnetic (M2) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis Raphael I, Mahesula S, Kalsaria K, Kotagiri V, Purkar AB, Anjanappa M, Shah D, Pericherla V, Jadhav YLA, Raghunathan R, Vaynberg M, Noriega D, Grimaldo NH, Wenk C, Gelfond JAL, Forsthuber TG, Haskins WE |
3820 - 3829 |
Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosis Mahesula S, Raphael I, Raghunathan R, Kalsaria K, Kotagiri V, Purkar AB, Anjanappa M, Shah D, Pericherla V, Jadhav YLA, Gelfond JAL, Forsthuber TG, Haskins WE |
3830 - 3834 |
Protein and peptide profiling as a tool for biomarker discovery in depression AlAwam K, Dudley E, Donev R, Thome J |
3835 - 3848 |
Hypothermic regulation of astrocyte proteome profile in experimental stroke Seo M, Kim JH, Cho YE, Baek MC, Suk K |
3850 - 3850 |
Alternating current cloud point extraction on a microchip: A comprehensive study (vol 33, pg 3159, 2012) Sasaki N |